SMAD4 and pancreatic neoplasm: SMAD4/DPC4 deletions occur late in the transformation of pancreatic intraepithelial neoplasia to pancreatic cancer [77], with heterozygous deletions occurring in nearly 60% of human pancreatic cancers and approximately 50% exhibiting homozygous deletions or intragenic inactivating mutations [9].